Legal & General Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.2M | Buy |
399,426
+16,499
| +4% | +$2.07M | 0.01% | 615 |
|
|
2025
Q1 | $42.4M | Buy |
382,927
+37,237
| +11% | +$4.12M | 0.01% | 645 |
|
|
2024
Q4 | $47.2M | Sell |
345,690
-44,895
| -11% | -$6.13M | 0.01% | 627 |
|
|
2024
Q3 | $45M | Sell |
390,585
-11,914
| -3% | -$1.37M | 0.01% | 654 |
|
|
2024
Q2 | $55.4M | Sell |
402,499
-117
| -0% | -$16.1K | 0.02% | 603 |
|
|
2024
Q1 | $55.5M | Sell |
402,616
-38,891
| -9% | -$5.36M | 0.02% | 610 |
|
|
2023
Q4 | $58.2M | Sell |
441,507
-6,641
| -1% | -$875K | 0.02% | 602 |
|
|
2023
Q3 | $50.4M | Sell |
448,148
-9,584
| -2% | -$1.08M | 0.02% | 622 |
|
|
2023
Q2 | $43.2M | Sell |
457,732
-36,186
| -7% | -$3.41M | 0.01% | 667 |
|
|
2023
Q1 | $50M | Buy |
493,918
+2,696
| +0.5% | +$273K | 0.02% | 627 |
|
|
2022
Q4 | $58.7M | Sell |
491,222
-5,816
| -1% | -$695K | 0.02% | 583 |
|
|
2022
Q3 | $52.8M | Sell |
497,038
-9,672
| -2% | -$1.03M | 0.02% | 612 |
|
|
2022
Q2 | $49.4M | Buy |
506,710
+33,279
| +7% | +$3.24M | 0.02% | 638 |
|
|
2022
Q1 | $44.4M | Buy |
473,431
+26,254
| +6% | +$2.46M | 0.01% | 692 |
|
|
2021
Q4 | $38.1M | Sell |
447,177
-2,944
| -0.7% | -$251K | 0.01% | 738 |
|
|
2021
Q3 | $43.2M | Buy |
450,121
+1,625
| +0.4% | +$156K | 0.01% | 707 |
|
|
2021
Q2 | $43.6M | Buy |
448,496
+42,915
| +11% | +$4.18M | 0.01% | 712 |
|
|
2021
Q1 | $39.4M | Buy |
405,581
+66,890
| +20% | +$6.51M | 0.01% | 717 |
|
|
2020
Q4 | $32.5M | Sell |
338,691
-29,488
| -8% | -$2.83M | 0.01% | 730 |
|
|
2020
Q3 | $35.4M | Sell |
368,179
-9,306
| -2% | -$895K | 0.02% | 680 |
|
|
2020
Q2 | $46.1M | Buy |
377,485
+94,980
| +34% | +$11.6M | 0.02% | 587 |
|
|
2020
Q1 | $24.5M | Buy |
282,505
+21,196
| +8% | +$1.83M | 0.01% | 686 |
|
|
2019
Q4 | $28.1M | Buy |
261,309
+197,544
| +310% | +$21.2M | 0.01% | 732 |
|
|
2019
Q3 | $5.75M | Buy |
63,765
+11,467
| +22% | +$1.03M | ﹤0.01% | 1233 |
|
|
2019
Q2 | $4.42M | Buy |
52,298
+718
| +1% | +$60.6K | ﹤0.01% | 1336 |
|
|
2019
Q1 | $4.54M | Sell |
51,580
-8,987
| -15% | -$792K | ﹤0.01% | 1244 |
|
|
2018
Q4 | $4.33M | Sell |
60,567
-4,598
| -7% | -$328K | ﹤0.01% | 1136 |
|
|
2018
Q3 | $8.01M | Buy |
65,165
+25,365
| +64% | +$3.12M | 0.01% | 949 |
|
|
2018
Q2 | $3.91M | Sell |
39,800
-5,011
| -11% | -$492K | ﹤0.01% | 1280 |
|
|
2018
Q1 | $3.72M | Sell |
44,811
-561
| -1% | -$46.5K | ﹤0.01% | 1265 |
|
|
2017
Q4 | $3.52M | Buy |
45,372
+8,875
| +24% | +$689K | ﹤0.01% | 1294 |
|
|
2017
Q3 | $2.24M | Buy |
36,497
+4,638
| +15% | +$284K | ﹤0.01% | 1525 |
|
|
2017
Q2 | $1.47M | Buy |
31,859
+2,554
| +9% | +$117K | ﹤0.01% | 1684 |
|
|
2017
Q1 | $1.27M | Buy |
29,305
+19,955
| +213% | +$864K | ﹤0.01% | 1710 |
|
|
2016
Q4 | $362K | Buy |
9,350
+1,136
| +14% | +$44K | ﹤0.01% | 2063 |
|
|
2016
Q3 | $415K | Buy |
8,214
+1,215
| +17% | +$61.4K | ﹤0.01% | 1792 |
|
|
2016
Q2 | $318K | Sell |
6,999
-12,289
| -64% | -$558K | ﹤0.01% | 1584 |
|
|
2016
Q1 | $759K | Buy |
19,288
+1,862
| +11% | +$73.3K | ﹤0.01% | 1205 |
|
|
2015
Q4 | $980K | Buy |
17,426
+958
| +6% | +$53.9K | ﹤0.01% | 1160 |
|
|
2015
Q3 | $628K | Buy |
16,468
+688
| +4% | +$26.2K | ﹤0.01% | 1236 |
|
|
2015
Q2 | $750K | Buy |
15,780
+1,926
| +14% | +$91.5K | ﹤0.01% | 1214 |
|
|
2015
Q1 | $567K | Buy |
13,854
+2,418
| +21% | +$99K | ﹤0.01% | 1254 |
|
|
2014
Q4 | $258K | Hold |
11,436
| – | – | ﹤0.01% | 1455 |
|
|
2014
Q3 | $178K | Buy |
+11,436
| New | +$178K | ﹤0.01% | 1568 |
|